About
VoiceMed develops AI-driven vocal biomarker technology to enable non-invasive digital health checks for chronic respiratory diseases such as COPD, facilitating early detection, monitoring, and smoking cessation support via smartphone.
Explore VoiceMed's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.